The Bain Capital Vitabiotics acquisition is one of the most significant cross-border private equity transactions of 2026, spanning the UK, India, and Africa. Six law firms across multiple jurisdictions advised on the $1 billion deal, fielding some of the largest transaction teams seen in a single consumer-healthcare buyout this year. The deal remains subject to customary regulatory approvals.
Introduction
Bain Capital, a leading global private investment firm, has agreed to acquire Vitabiotics Limited, including its UK operations and the wider VB Group. The acquisition encompasses Meyer Organics Private Limited in India and African operations including VB Egypt. The deal was announced on 24 July 2026, with Bain Capital’s Asia Private Equity team leading the investment, supported by the firm’s global platform.
Vitabiotics is a leading British nutraceutical company founded in 1971 by Professor Kartar Lalvani. The company has pioneered advances in nutritional healthcare for 55 years, with a portfolio that includes supplement brands such as Perfectil, Pregnacare, Wellman, Wellwoman, and Menopace. The transaction brings together one of the world’s leading healthcare and consumer investors with one of the most recognised independent vitamins, minerals, and supplements businesses globally.
Deal Value
The transaction is valued at $1 billion, encompassing Vitabiotics’ UK operations and the wider VB Group, including its Indian and African subsidiaries.
Legal Teams Involved
Six law firms advised across the transaction, covering the buyer, sellers, and financing arrangers. Full team details, as provided, are set out below. For a running tracker of major deal mandates, see the Deal Meter.
Kirkland & Ellis — Lead Legal Counsel to Bain Capital (Overall Transaction)
- Jacob Traff (Partner)
- Srinivas S. Kaushik, P.C. (Partner)
- James Whybrow (Partner)
- Carmella Crinnion (Partner)
- Angie Ertel (Associate)
- Emma Luo (Associate)
- Edward Mort (Associate)
Tax: Alan Walker (Partner), Michael Akpomiemie (Partner), Bryan Leighton (Associate)
Technology & IP Transactions: Emma L. Flett (Partner), Ben Zeris (Partner), Stephen Coudounaris (Associate)
Debt Finance: Jacqueline Zheng (Partner), Sam Sherwood (Partner), Christopher Shield (Partner), Karen Ho (Partner)
Khaitan & Co — Advised Bain Capital (India Leg)
Further details on team composition were not disclosed.
AZB & Partners — Advised Vitabiotics and Meyer Organics Private Limited
- Zia Mody (Founder & Managing Partner)
- G. Padmanabhan (Senior Partner)
- Nandish Vyas (Senior Partner)
- Anshuman Bharadwaj (Partner)
- Prerak Ved (Partner)
- Deepti Narayanan (Senior Associate)
- Labdhi Doshi (Senior Associate)
- Priya Venkatesan (Senior Associate)
Macfarlanes — Lead Legal Counsel to Vitabiotics (Overall Transaction)
M&A Team:
- Tim Redman (Partner)
- Alice Temkin (Partner)
- Stephen Pike (Sponsor Solutions Partner)
- Robert Longman (Senior Associate), Emma Wolf (Senior Associate), San-Marie Saaiman (Senior Associate), Natasha Sellayah (Senior Associate)
- Jamie Kelly (Associate), Sanjana Singh (Associate), Finn Marshall (Associate), Rhian Edwards (Associate), Harris Grigoriou (Associate)
Trust and Tax:
- Jonathan Arr (Partner), Piers Barclay (Partner), Chloe Edworthy (Partner), Greg Price (Partner), Gideon Sanitt (Partner), Mark Stichbury (Partner)
- Emma Cohen (Senior Counsel), Joanna Constantis (Senior Counsel), Beth Leggate (Senior Counsel)
- Sarah-Louise Fernandez (Senior Associate), Will Fletcher (Senior Associate), Carrie Holmes (Senior Associate), Ed Parry-Smith (Senior Associate)
- Mollie Biggadike (Associate), Beth Cooper (Associate), Jamie Golding (Associate), Ellie Herve (Associate), Susie Hucker (Associate), George Mitkov (Associate), Luca Parrott (Associate), Chris Ward (Associate)
Competition: Malcolm Walton (Partner), Matthew Jones (Senior Associate), Megan Humphreys (Associate)
Property: Clare Breeze (Partner), Helen Sculthorpe (Senior Counsel), Russell Fancourt (Associate)
Commercial: Martha Campbell (Senior Counsel), Julia Inselseth (Associate)
Advisory: Lorna Emson (Partner), Francis Bond (Senior Associate)
Baker McKenzie — Advised Professor Ajit Lalvani (Seller)
Baker McKenzie advised Professor Ajit Lalvani, one of the sellers and the son of Vitabiotics founder Professor Kartar Lalvani, on the sale of Vitabiotics to Bain Capital.
- David Scott (London Head of M&A)
- Ryan Howlett (Senior Associate)
- Nikki Bradford (Associate)
A&O Shearman — Advised the Arrangers (Committed Financing)
A&O Shearman advised the arrangers in relation to the committed financing for the acquisition.
- Matt Del Rosso (Partner)
- Gautam Narasimhan (Partner)
- Daniel Tan (Partner)
- Glen Tay (Associate)
- Jia Min Lim (Associate)
- Annika Shah (Trainee)
- Hannah McGreevy (Trainee)
Significance and Impact
This transaction marks a defining moment for the Indian and global nutraceuticals sector, bringing a 55-year-old British family-built business under private equity ownership for the first time. The inclusion of Meyer Organics Private Limited makes the India leg one of the more consequential elements of the deal, requiring separate domestic legal advisory mandates and regulatory navigation — reflected in the parallel instructions to both Khaitan & Co and AZB & Partners.
Bain Capital has stated it will leverage its local market expertise in India, along with sector knowledge, portfolio assets, and global capabilities, to assist Vitabiotics in expanding its brands and enhancing its international presence. Priority growth markets identified include MENA and China. The six-firm legal structure — spanning London, New York, Hong Kong, Mumbai, and Singapore — underscores the multi-jurisdictional complexity of the transaction.
The deal is also notable as part of a broader wave of US private equity acquisitions of profitable UK consumer and healthcare businesses in 2026, with the UK’s legal and regulatory environment continuing to attract cross-border deal activity.
The Bain Capital Vitabiotics acquisition is a landmark cross-border private equity deal valued at $1 billion, with legal advisory roles spread across six international and Indian law firms. The transaction is subject to customary regulatory approvals, and completion timelines were not disclosed. Once closed, it will mark the beginning of a new growth chapter for Vitabiotics and its subsidiaries, including Meyer Organics in India.
Disclaimer: This article is for informational purposes only and does not constitute legal advice. It is based on the details provided and publicly available sources.
